No glue no sutures - Natural hemostasis for conjunctival autografting following pterygium excision

---

Original Article

Author Details : DN Prakash, Shreeshruthi N, Satish K3, Shreedevi B, Sujata

Volume : 3, Issue : 1, Year : 2017

Article Page : 61-66

Suggest article by email

Get Permission

---

Abstract

Introduction and purpose of the study: To study the effectivity of natural hemostatic mechanism for attachment of the graft, reducing the cost as well as risks associated with the use of fibrin glue and post-op discomfort associated with sutures.
Materials and Methods: Prospective comparative study was carried on 60 eyes of 51 patients undergoing pterygium excision with conjunctival autografting for primary pterygium. Patients were randomised into two groups. Sutures used in one of the groups and natural hemostasis in the other, for attaching the graft. Operating time, post-op graft stability, discomfort and recurrence rate were studied.
Result: Operating time (12mins) and post-op discomfort was significantly reduced in sutureless group compared to sutured group (20mins). Post-op day1, 2 out of 30 eyes had graft displacement in sutureless group compared to 1 in sutured group. 2 out of 30 eyes had recurrence in sutureless group compared to 1 in sutured group.
Conclusion: Natural hemostatic mechanism for attaching conjunctival limbal autografting considerably decreased the operative time and post-op discomfort in patients with primary pterygium.

Keywords: Autograft, Glue, Natural hemostasis, Pterygium, Sutureless

How to cite : Prakash D, Shreeshruthi N, Satish K3, Shreedevi B, Sujata, No glue no sutures - Natural hemostasis for conjunctival autografting following pterygium excision. IP Int J Ocul Oncol Oculoplasty 2017;3(1):61-66

This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.